|
- Pfizer: One of the worlds premier biopharmaceutical companies
Pfizer has your back in the fight against cancer With over 50+ programs, 80+ clinical trials worldwide and 40% of our R D budget dedicated to oncology, we're committed to advancements in cancer care
- Pfizer’s Core Values of Social Responsibility and Philanthropy
Jeff Kindler, Chairman and CEO of Pfizer, announces the next step in the company's evolution and outlines the company's plan to establish smaller operating units designed to enhance innovation and accountability, while drawing upon the advantages of Pfizer's scale and resources
- Celebrating 175 Years of Changing Lives at Pfizer
Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart with the driving ambition to discover innovations that help people Over the past 175 years, we have achieved that and so much more To date, we’ve reached billions of patients with our medicines and vaccines
- Our Products: Holding the Promise of a Breakthrough - Pfizer
In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription
- Pfizer Company Fact Sheet | Key Pharma Consumer Health Products | Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products
- History - Pfizer
Pfizer invests an industry leading $5 1 billion in research and development and launches Vfend® (voriconazole), an orally and intravenously administered antifungal indicated for treatment of serious fungal infections
- Careers | Pfizer
What is something you would tell someone who is just starting their career with Pfizer? “Pfizer aces at taking care of its people From educational assistance to health care subsidy in retirement, Pfizer knows that its best asset are the people who work here ”
- Accelerating Breakthroughs to Outdo Cancer | Pfizer
Pfizer has a deep and diverse pipeline within our focused therapeutic areas Our goal is to double the number of patients treated with our cancer medicines by 2030 The below pipeline tracks the progress of our medicines in development, from small-scale Phase 1 studies to large-scale Phase 3 trials in progress 13
|
|
|